The companies moving biosimilars forward belong in this room.

PARITY is building a focused partner community around the capabilities that turn biosimilar science into reliable supply, market access, and adoption.

Sponsor announcements in progressThis page will be updated as each partnership is confirmed.

Confirmed partners

A roster built with intention.

We are currently finalizing the first PARITY 2027 partnerships. Confirmed sponsor names and logos will be published here only after agreements are complete.

That approach keeps the page accurate and gives every announced partner a clear place in the biosimilars value chain.

First announcement wave

Coming soon.

Partner conversations are underway across manufacturing, analytics, commercialization, and access.

PhiladelphiaSeptember 21–23, 2027

Who we are looking for

Partners with a real role in the outcome.

The strongest PARITY sponsors bring expertise the audience can use—not simply a logo to display.

Development & manufacturing

CDMOs, process-development teams, scale-up specialists, fill-finish providers, and commercial manufacturing partners.

Analytics, quality & comparability

Analytical platforms, characterization technologies, reference standards, quality systems, and laboratory partners.

Clinical & regulatory strategy

CROs, regulatory consultancies, evidence-generation partners, pharmacovigilance teams, and submission specialists.

Market access & commercialization

Pricing, reimbursement, payer research, launch strategy, provider education, and patient-access organizations.

Supply chain & delivery

Packaging, cold-chain, serialization, logistics, distribution, device, and resilient supply-network providers.

Data, legal & transaction services

Digital platforms, AI and automation, IP counsel, licensing advisors, investors, and partnership-enablement teams.

The fit standard

Credibility before promotion.

PARITY partnerships should improve the room: sharper evidence, stronger operating insight, or better pathways to collaboration.

01
Relevant capability
A clear connection to biosimilar development, manufacturing, access, adoption, or transactions.
02
Evidence-led contribution
Practical experience, data, or case studies that help delegates make better decisions.
03
Partnership mindset
A willingness to build useful conversations around audience needs rather than deliver a sales pitch.
04
Long-term relevance
Solutions and expertise that remain valuable beyond a single conference interaction.

Partner with PARITY

Help shape the room the biosimilars market needs.

If your organization strengthens the path from development to adoption, we would like to understand where your expertise fits.

Start a partnership conversation

The full sponsorship prospectus is shared directly by the PARITY team after an initial conversation.